Studies on Tumors of the Thyroid

Launched by NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES (NIDDK) · Nov 3, 1999

Keywords

ClinConnect Summary

This clinical trial is studying different types of thyroid cancer, including Hurthle Cell, Tall Cell Variant, Follicular, and Papillary thyroid cancers. The main goal is to improve how doctors diagnose and treat thyroid nodules and cancer. Participants will be individuals who have been diagnosed with or are suspected to have a thyroid nodule or thyroid cancer. The study will involve standard medical tests, as well as some additional tests for research purposes. Researchers will also collect blood and tissue samples to learn more about the genetics of thyroid cancer.

To take part in this study, participants can be adults or children aged 6 months and older who have thyroid nodules or cancer, or family members at risk of developing thyroid cancer due to genetic factors. However, those with serious health issues that could affect treatment or testing will not be eligible. If you join the study, you'll go through various tests and procedures, and your contributions will help researchers better understand and potentially improve thyroid cancer care in the future.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• In order to be eligible to participate in this study, an individual must meet all of the following criteria:
• • 1. Male or female, adults or children \>= 6 months+.
• • 2. Patients with known or suspected thyroid nodules and/or thyroid cancer.
• • 3. At risk family members of patients who have a genetic susceptibility to developing thyroid cancer.
• EXCLUSION CRITERIA:
• An individual who meets any of the following criteria will be excluded from participation in this study:
• • 1. Serious underlying medical conditions that restrict diagnostic testing or therapy such as renal failure, congestive cardiac failure or active coexisting non-thyroid carcinoma requiring intervention before thyroid cancer is addressed.

Trial Officials